TIGeR: Translational Implementation of Genomics for Rare diseases
The TIGeR team, in close collaboration with Alberta Precision Laboratories (APL), is facilitating in-province clinical genome-wide sequencing (GWS). TIGeR’s vision is to develop, evaluate and implement a large scale clinical GWS service and a governance framework that integrates genomics data provincially, nationally and internationally using a learning lab system that will continually optimize and improve performance.
All patients’ samples and data will remain in Alberta, and will be managed and governed by APL policies.
At this time in the project, TIGeR offers exome sequencing and the following panels on an exome backbone:
- Ataxia (219 genes)
- Charcot-Marie-Tooth (116 genes)
- Complex Immune Dysregulation (641 genes)
- Epilepsy (765 genes)
- Growth and Related Disorders (520 genes)
- Retinal Dystrophy (314 genes)
- Movement Disorders (609 genes)
- Spastic Paraplegia (75 genes)
If you would like more information, please contact us at Tiger.Team@albertaprecisionlabs.ca.
